Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
A wide-market index fund retirement portfolio emphasizes broad market coverage, aiming for steady growth with manageable fees.
28,259 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
Ford famously pulled back from most sedans years ago. This article examines the strategic pivot, what a sedan comebac...
As August approaches, a key SpaceX catalyst coming could shift the balance for investors. This guide breaks down what...
AGNC Investment's more than 13.5% yield looks tempting, especially in a low-rate world. Yet looming Fed rate changes ...
As July rolls in, space stocks attract attention—but not all rockets rise equally. This guide spotlights two practica...
Kraken has reportedly secured access to the Fed’s core payment systems, a move that could accelerate settlement times...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Multicoin Capital disclosed a substantial Zcash position, triggering a double-digit rally in ZEC. The move underscore...
This comprehensive guide breaks down Exzeo’s Q1 2026 results, reveals the drivers behind exzeo (xzo) 2026 earnings, a...
The Roundhill Memory ETF fell roughly 5% in early trading after a dramatic six-week breakout. Analysts say profit-tak...
New Hampshire lawmakers rejected the final vote on a $100 million bitcoin bond proposal, signaling a setback for a pl...